NeoGenomics Inc.

NeoGenomics operates a network of cancer-focused genetic testing laboratories in the U.S. as well as a laboratories in Switzerland and Singapore that provides genetic and molecular testing services. The company provides clinical diagnostic services to pathologists, oncologists, urologists, hospitals, and other laboratories as well as providing clinical trial services to pharmaceutical firms. The company provides the following types of genetic and molecular testing services: cytogenetics, fluorescence in-situ hybridization, flow cytometry, immunohistochemistry and digital imaging, molecular testing, and pathology consultation.
  • TickerNEO
  • ISINUS64049M2098
  • ExchangeNASDAQ Stock Market
  • SectorHealth Care Equipment & Services
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for NEO

ValuEngine Rating and Forecast Report for NEO

ValuEngine Toronto Quantitative Stock Report for NEO

ValuEngine Toronto Quantitative Stock Report for NEO

ValuEngine Toronto Quantitative Stock Report for NEO

ValuEngine Toronto Quantitative Stock Report for NEO

ValuEngine Rating and Forecast Report for NEO

ValuEngine Rating and Forecast Report for NEO

ValuEngine Rating and Forecast Report for NEO

ValuEngine Rating and Forecast Report for NEO

Feasibility Study Results in December to be a Catalyst for this Junior

Feasibility Study Results in December to be a Catalyst for this Junior